Click a link below to view the mailing archive as if it had been sent to you.
| 2016-12-30 12:15 | | Pfizer partner Opko reports a PhIII failure for growth hormone, but tries to steer out of a crash and more... |
| 2016-12-30 00:15 | | Merck’s Zetia and Vytorin: More Generic Competition in 2017 and more... |
| 2016-12-29 12:15 | | The FDA's promo police slap four more pharmas in year-end enforcement spree and more... |
| 2016-12-29 00:15 | | STAT’s stats of the year: 2016 by the numbers and more... |
| 2016-12-28 12:15 | | Why Is Enbrel So Important for Amgen? and more... |
| 2016-12-28 00:15 | | Seattle Genetics shares drop 13% on news of FDA holds on several early-stage clinical trials |
| 2016-12-27 12:15 | | Coming soon to the Nasdaq: Biogen's hemophilia spinoff and more... |
| 2016-12-25 00:15 | | Novartis, Sun Pharma enter deal for oncology drug Odomzo and more... |
| 2016-12-23 12:15 | | [video]J&J-Actelion Talks Resume: What’s Next for Sanofi? and more... |
| 2016-12-22 12:15 | | Teva agrees to pay more than $519 mln to settle bribe allegations - DoJ and more... |
| 2016-12-21 12:15 | | Actelion shares gain on report of progress in Sanofi talks and more... |
| 2016-12-21 00:15 | | Here's Why Investors Weren't Excited About Biogen's New CEO and more... |
| 2016-12-19 12:15 | | The Best Biopharma CEOs of 2016 Are... and more... |
| 2016-12-18 00:15 | | Could These 2 Small Biotechs Beat Allergan and Gilead Sciences? and more... |
| 2016-12-16 12:15 | | Sanofi Said to Be in Advanced Talks to Acquire Actelion and more... |
| 2016-12-16 00:15 | | Agios Pharma shares dive after anemia treatment development halted and more... |
| 2016-12-15 12:15 | | Lilly forecasts 2017 revenue, profit above estimates and more... |
| 2016-12-14 12:15 | | It’s the law: Obama signs widely popular 21st Century Cures Act and more... |
| 2016-12-14 00:15 | | Three top Valeant execs jump ship after grabbing $1M retention bonuses and more... |
| 2016-12-13 12:15 | | GSK preps for vaccine R&D expansion, 200 hires for new global hub and more... |
| 2016-12-13 00:15 | | Pfizer bankrolls an oncolytics biotech upstart with an eye on a future buyout and more... |
| 2016-12-12 12:15 | | Alexion Pharmaceuticals says CEO, CFO resign, shares slump and more... |
| 2016-12-12 00:15 | | Medtech approvals: FDA releases November 2016 PMA approvals and more... |
| 2016-12-11 12:15 | | Your attention, please: AstraZeneca asks for a moment of rapt silence, for a BLA acceptance? and more... |
| 2016-12-10 12:15 | | Sanofi to cut US diabetes staff and more... |
| 2016-12-09 12:15 | | Eli Lilly to pay AstraZeneca $30 million as part of a collaboration on an Alzheimer's treatment and more... |
| 2016-12-09 00:15 | | AstraZeneca cutting 700 U.S jobs, 120 in Phila. region and more... |
| 2016-12-08 12:15 | | What Trump's Win Might Mean for Pharma and more... |
| 2016-12-08 00:15 | | Abbott Seeks To Terminate Alere Acquisition: 'Not The Company We Agreed To Buy' and more... |
| 2016-12-07 12:15 | | Mylan eyes up to 3,500 layoffs in post-M&A cost-cutting drive and more... |
| 2016-12-07 00:15 | | Gilead Sciences Inc.'s Worst Moves in 2016 and more... |
| 2016-12-06 12:15 | | Top Actelion shareholder says backs J&J deal above 246 Sfr/share and more... |
| 2016-12-06 00:15 | | Sanofi to Explore Counterbid for Actelion Amid J&J Talks and more... |
| 2016-12-05 12:15 | | Celebrating BioPharma: Of Triple Crowns And Unicorns and more... |
| 2016-12-05 00:15 | | 7 of the Most Shocking Biotech Pipeline Blowups of 2016 and more... |
| 2016-12-03 12:15 | | Celgene buys Acetylon, keeps what it wants and spins the rest back out as Regenacy and more... |
| 2016-12-03 00:15 | | Yes, Martin Shkreli can drop his bad boy persona, at least for one moment and more... |
| 2016-12-02 12:15 | | Mylan CEO defends EpiPen strategy, questions pricing model in the U.S. and more... |
| 2016-12-02 00:15 | | Regeneron, Sanofi Drug Delayed by Plant Snag and more... |
| 2016-12-01 12:15 | | Pfizer Partners With IBM Watson To Advance Cancer Drug Discovery and more... |
| 2016-12-01 00:15 | | Ariad's Iclusig Gets FDA OK and Label Update and more... |
